Major areas of activity.

  • Inflammation and Cardiovascular Disease (focus on RA and SLE and atherosclerosis)
  • Cardiovascular Pharmacogenetics (focus on adrenergic receptor genetic variation)
  • Pharmacogenetics and Drug Response (focus on warfarin and other drugs whose metabolism is affected by genetic variation, including ICU drugs, and statins)
  • Drug Safety (focus on sudden death, opioids, and serious drug interactions.